Digital healthcare company Noom has partnered with Liviniti, a national pharmacy benefit manager (PBM), to introduce a comprehensive metabolic offering for plan sponsors and employees. The collaboration includes Noom Weight, Noom Diabetes Prevention Program, and the newly launched Noom GLP-1 Companion.
Designed for individuals taking GLP-1s for weight loss, the program assists members through various phases of their weight loss journey, offering support in nutrition, exercise, medication adherence, and long-term weight maintenance. The GLP-1 Companion addresses challenges associated with GLP-1 use, such as muscle loss and potential weight regain, aiming to provide holistic treatment plans through coaching and content support.
Noom's GLP-1 Companion program integrates with pharmacy benefit manager prior authorisation processes, incorporates a tailored approach to food colour-coding for GLP-1 users, and features tools like a protein-tracking tool, fitness-focused lessons, and expert guidance on side effects and complications. Liviniti, as a pioneer in pharmacy benefit innovation, is the first PBM to collaborate with Noom in optimising weight management outcomes with the GLP-1 Companion. The program is set to be available to Liviniti clients and their members from March 2024.
Noom's CEO Geoff Cook expressed the company's commitment to delivering a comprehensive GLP-1 course of care, emphasising the importance of lifestyle in GLP-1 success. Noom has been involved in GLP-1 companion support since 2018, and the GLP-1 Companion program builds on the success of an earlier GLP-1 program, engaging over 65,000 users. Additionally, Liviniti clients seeking stress and mental wellness support for their members can access Noom's stress management program, Noom Mood, as part of the collaboration.
Click here to read the original news story.